CompletedNCT02200406
Desvenlafaxine for Depression During Opioid Treatment
About this title
Read the official source — NCT02200406Medication studyAges 18–65Canada
Understand this study
Who was this study for?
This study was for people with depression. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
- Listed locations
- MontrealSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateJuly 2014
- Recruitment status
- Completed
- Enrollment listed in the registry
- 18
- Sponsor
- Centre hospitalier de l'Université de Montréal (CHUM)
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Canada
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT02200406
- Official title
Show the full official title
An Open-Label Pilot Study of Desvenlafaxine for Opioid-Dependent Patients With Comorbid Depression
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Montreal
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Centre hospitalier de l'Université de Montréal (CHUM), a university.
Did this study involve medication?
Yes. The study involved medication, including Desvenlafaxine.
Who was this study for?
This study was for people with depression. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
